Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Turn Therapeutics Inc.
Market Cap
$346.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$348.81M
Net Profit Margin
-184.60%
TTM Avg
-1235.34%
3Y Avg
-1300.41%
5Y Avg
-438.85%
Market Cap
$344.82M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$349.74M
Net Profit Margin
8.59%
TTM Avg
7.90%
3Y Avg
10.47%
5Y Avg
19.48%
Market Cap
$353.49M
Net Profit Margin
-1786.27%
TTM Avg
-1435.22%
3Y Avg
-1851.09%
5Y Avg
-9692.20%
Market Cap
$353.82M
Net Profit Margin
-96.89%
TTM Avg
-148.47%
3Y Avg
-151.80%
5Y Avg
-119.69%
Market Cap
$354.03M
Net Profit Margin
4.81%
TTM Avg
5.28%
3Y Avg
5.16%
5Y Avg
8.74%
Market Cap
$359.88M
Net Profit Margin
-5.49%
TTM Avg
-11.37%
3Y Avg
-410.78%
5Y Avg
-2049.25%
Market Cap
$359.28M
Net Profit Margin
0.00%
TTM Avg
-11651.99%
3Y Avg
-6142.69%
5Y Avg
-4693.07%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | $346.88M | 0.00% | 0.00% | N/A | N/A |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $348.81M | -184.60% | -1235.34% | -1300.41% | -438.85% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.82M | 0.00% | 0.00% | 0.00% | 0.00% |
| Embecta Corp. (EMBC)vs › | $349.74M | 8.59% | 7.90% | 10.47% | 19.48% |
| Ocugen, Inc. (OCGN)vs › | $353.49M | -1786.27% | -1435.22% | -1851.09% | -9692.20% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.82M | -96.89% | -148.47% | -151.80% | -119.69% |
| Viemed Healthcare, Inc. (VMD)vs › | $354.03M | 4.81% | 5.28% | 5.16% | 8.74% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.88M | -5.49% | -11.37% | -410.78% | -2049.25% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $359.28M | 0.00% | -11651.99% | -6142.69% | -4693.07% |
| Opus Genetics, Inc. (IRD)vs › | $361.82M | -1091.82% | -436.37% | -220.06% | -1750.93% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2024-06-30 | 0.00% |
